Nanochemistry offering innovative solutions for drug development, delivery, and diagnostics. At the nanoscale, materials exhibit unique properties that can be harnessed to enhance the therapeutic efficacy of pharmaceutical compounds. Nanostructured drug delivery systems, such as liposomes, micelles, and nanoparticles, enable targeted and controlled release of drugs, optimizing their bioavailability and minimizing side effects. Additionally, nanochemistry facilitates the design of nanoscale drug carriers that can overcome biological barriers, improving drug penetration and cellular uptake.
The application of nanotechnology in pharmaceuticals extends beyond drug delivery, encompassing diagnostic tools and imaging agents that enhance the precision and sensitivity of disease detection. Moreover, nanochemistry enables the synthesis of nanoscale materials for theranostic purposes, combining therapeutic and diagnostic functionalities in a single platform. The interdisciplinary nature of nanochemistry in the pharmaceutical field underscores its potential to revolutionize drug development and patient care, offering tailored solutions for complex medical challenges.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia